<DOC>
	<DOCNO>NCT02242864</DOCNO>
	<brief_summary>The primary objective evaluate effect treatment Micardis® MicardisPlus® blood pressure . Secondary objective effect Micardis® / MicardisPlus® metabolic parameter ( triglyceride , cholesterol , LDL blood glucose , insulin Homeostasis Model Assessment ( HOMA ) -index HbA1c ) patient essential hypertension diabetes mellitus</brief_summary>
	<brief_title>Study Evaluate Effect Treatment With Micardis® MicardisPlus® Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan , hydrochlorothiazide drug combination</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Age &gt; 18 year Hypertension Diabetes mellitus Age &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>